Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Edward H. Overstreet

Edward H. Overstreet, Valencia, CA US

Patent application numberDescriptionPublished
20090062896Minimizing Trauma During and After Insertion of a Cochlear Lead - A method for delivering dexamethasone base (DXMb) via an implantable electrode includes coupling DXMb to the implantable electrode and inserting the implantable electrode into animal tissue, the DXMb eluting into the animal tissue. An implantable nerve stimulating device includes an elongated member having a distal end bearing at least one electrode; and DXMb coupled to the elongated member, the DXMb being eluted into tissue surrounding the elongated member.03-05-2009
20090264962Electric and Acoustic Stimulation Fitting Systems and Methods - Methods and systems for modifying the parameters of at least one hearing device for a patient with residual hearing provide needed orchestration of acoustic and electric stimulation of patients wearing such devices.10-22-2009
20090264963Electric and Acoustic Stimulation Fitting Systems and Methods - Methods and systems for modifying the parameters of at least one hearing device for a patient with residual hearing provide needed orchestration of acoustic and electric stimulation of patients wearing such devices.10-22-2009
20090292237Modular Drug Delivery System for Minimizing Trauma During and After Insertion of a Cochlear Lead - A system for delivering therapeutic agents to biological tissue includes a surgically implantable lead configured to be inserted into the biological tissue, the surgically implantable lead including a preformed cavity; and a modular capsule containing a therapeutic agent which includes dexamethasone base; the modular capsule being secured within the preformed cavity; the modular capsule releasing the therapeutic agent into the biological tissue. A method of delivering therapeutic agents to biological tissue includes obtaining a surgically implantable lead with a preformed cavity; obtaining a modular capsule containing a therapeutic agent comprising dexamethasone base and securing it within the preformed cavity; and inserting the surgically implantable lead into the biological tissue.11-26-2009
20100070000METHODS AND SYSTEMS OF CONVEYING FINE STRUCTURE INFORMATION TO A COCHLEAR IMPLANT PATIENT - An exemplary method of conveying fine structure information to a cochlear implant patient includes dividing an audio signal into a plurality of analysis channels, generating electrical stimulation in accordance with the information contained within each of the analysis channels, applying the electrical stimulation to at least one stimulation site within a patient via a plurality of stimulation channels, and at least partially isolating one of the stimulation channels from a rest of the stimulation channels, wherein fine structure information is conveyed to the patient via the isolated stimulation channel. Corresponding methods and systems are also disclosed.03-18-2010
20100114288COCHLEAR ELECTRODE INSERTION - A system for mechanically assisted insertion of an electrode includes: an insertion tool configured to insert the electrode into biological tissues; and a controller configured to control the insertion tool, in which the controller is further configured to select operating parameters comprising a maximum allowable force profile from a library of operating parameters, in which the maximum allowable force profile is generated from data recorded during a number of previous successful operations. Also, a method for insertion of a cochlear lead, includes: selecting operating parameters comprising a maximum allowable force profile from a library of operating parameters; inserting the cochlear lead while sensing real time force and position; and continuing the insertion while the real time force is below the maximum allowable force profile, in which the maximum allowable force profile is generated from data recorded during a number of previous successful operations.05-06-2010
20100318158Optimizing Pitch and Other Speech Stimuli Allocation in a Cochlear Implant - Errors in pitch (frequency) allocation within a cochlear implant are corrected in order to provide a significant and profound improvement in the quality of sound perceived by the cochlear implant user. In one embodiment, the user is stimulated with a reference signal, e.g., the tone “A” (440 Hz) and then the user is stimulated with a probe signal, separated from the reference signal by an octave, e.g., high “A” (880 Hz). The user adjusts the location where the probe signal is applied, using current steering, until the pitch of the probe signal, as perceived by the user, matches the pitch of the reference signal, as perceived by the user. In this manner, the user maps frequencies to stimulation locations in order to tune his or her implant system to his or her unique cochlea.12-16-2010

Patent applications by Edward H. Overstreet, Valencia, CA US

Edward H. Overstreet, Stevenson Ranch, CA US

Patent application numberDescriptionPublished
20080221640Multi-electrode stimulation to elicit electrically-evoked compound action potential - A multichannel neurostimulation device spatially spreads the excitation pattern in the target neural tissue by either: (1) rapid sequential stimulation of a small group of electrodes, or (2) simultaneously stimulating a small group of electrodes. Such multi-electrode stimulation stimulates a greater number of neurons in a synchronous manner, thereby increasing the amplitude of the extra-cellular voltage fluctuation and facilitating its recording. The electrical stimuli are applied simultaneously (or sequentially at a rapid rate) on selected small groups of electrodes while monitoring the evoked compound action potential (ECAP) on a nearby electrode. The presence of an observable ECAP not only validates operation of the implant device at a time when the patient may be unconscious or otherwise unable to provide subjective feedback, but also provides a way for the magnitude of the observed ECAP to be recorded as a function of the amplitude of the applied stimulus. From this data, a safe, efficacious and comfortable threshold level can be obtained which may be used thereafter as the initial setting of the stimulation parameters of the neurostimulation device, or to guide the setting of the stimulation parameters of the neurostimulation device.09-11-2008